Advertisement

Topics

Search Results for "Mdvp Drug"

12:30 EDT 26th July 2017 | BioPortfolio

Matching Channels

Matching News

FDA Approves First New ALS Drug in More than 20 Years

NewsThe Food and Drug Administration has approved the drug Radicava, also known as edaravone, for the treatment for amyotrophic lateral sclerosis (ALS). This is the first time an ALS drug has been cl...

FDA Asks Drug Company to Pull Painkiller in First

The U.S. Food and Drug Administration (FDA) announced today (June 8) that it has requested that Endo Pharmaceuticals, a drug company, remove the opioid painkiller Opana ER from the drug market. This ...

Shoppers Drug Mart launches proven add-on drug plan for Canada employers

Michael JohnsenThe HealthWATCH for Business drug plan focuses on better managing drug spending and is estimated to help save employers and their employees 5%-10% on their drug plan. read more

FDA Approves First New Drug to Treat ALS in 20 Years – WRAL.com

WRAL.comFDA Approves First New Drug to Treat ALS in 20 YearsWRAL.comThe Food and Drug Administration said Friday it had approved the first new drug in 20 years to treat the paralyzing disease ALS. The...

FDA Approves First New Drug to Treat ALS in 20 Years – NBCNews.com

NBCNews.comFDA Approves First New Drug to Treat ALS in 20 YearsNBCNews.comThe Food and Drug Administration said Friday it had approved the first new drug in 20 years to treat the paralyzing disease AL...

New Method Yields Shortcut in Drug Development

NewsThe majority of promising new drug candidates are effective only within the body’s cells, but quick general methods of determining intracellular drug quantities are lacking.

Anti-cancer drug gets a boost when combined with antirheumatic

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy.

Does drug detailing affect prescribing patterns?

The obvious answer seems to be ‘yes’.  Why would pharmaceutical companies spend billions of dollars on drug detailing (i.e., visits by pharmaceutical representatives to physicians to expl...

Matching PubMed Articles

Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.

Knowledge about drug-drug interactions commonly arises from preclinical trials, from adverse drug reports, or based on knowledge of mechanisms of action. Our aim was to investigate whether drug-drug i...

Identification of drug- and drug-metabolite immune responses originating from both naïve and memory T-cells.

Both naïve and memory T-cells from drug-naive donors can be stimulated by parent drug and drug haptens. Thus, drug-derived antigens can stimulate naïve T-cells alongside pre-existing memory T-cells ...

Trends in reports of driving following illicit drug consumption among regular drug users in Australia, 2007-2013: Has random roadside drug testing had a deterrent effect?

Driving following illicit drug consumption ('drug-driving') is a potential road safety risk. Roadside drug testing (RDT) is conducted across Australia with the dual aims of prosecuting drivers with dr...

Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

A robust literature documents generational trends in drug use. We examined the implications of changing national drug use patterns on drug injection histories of diverse people who inject drugs (PWID)...

Drug cue reactivity involves hierarchical instrumental learning: evidence from a biconditional Pavlovian to instrumental transfer task.

Drug cue reactivity plays a crucial role in addiction, yet the underlying mechanisms are poorly understood. According to the binary associative account, drug stimuli retrieve an expectation of the dru...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement